In recent years, modern technologies and devices for coagulation monitoring have demonstrated a multidisciplinary interest in assays and methods. Devices and equipment for point-of-care (POC) coagulation monitoring of whole blood or plasma could eliminate fundamental deficiencies of routine coagulation assays and tests. Quartz Crystal Microbalance with dissipation (QCM-D) is an emerging powerful biomedical device, and it has an outstanding potential in this perspective. This is 'first critical review' article' that focuses the applications of coagulation assays on QCM-D technique, and it covers the substantial scientific efforts from 2011 to January 2016. This article could provide baselines for coagulation assays on QCM-D technology for the future perspectives, ultra-refining the POC settings for laboratory and clinical methods levels in worldwide and far beyond.
Introduction
Quartz Crystal Microbalance with dissipation (QCM-D) is an emerging powerful biomedical device, and it has an outstanding potential for real application of pharmaceuticals 1 , clinical 2 and biomedical 3 studies. It is gaining popularity due to its costeffectiveness on comparing to its counterpart bio-sensor platforms 4 . QCM-D is unique 5 mass, viscosity or density sensitive device for liquids phases and it provides information from frequency and dissipation shifts 6, 7 .
QCM-D enables monitoring of whole kinetics of the coagulation, from starting of coagulation to the end in the form of total coagulation.
Coagulation times can be monitored both from frequency and dissipation shifts via different coagulation assays involving different reagents. Additional kinetic information in the form of total coagulation on QCM-D measurement curve is substantial support to POC settings. Merging biomedical engineering of ultra-sensitive thin films and coatings to the QCM crystals could reveal interesting facts, which are impossible on standard coagulation devices. These factors make QCM-D unique technique 8 . Monitoring of total coagulation is impossible on standard coagulation devices namely mechanical coagulometers because they pick one threshold point during coagulation process. Total coagulation point can be monitored from frequency and dissipation curves. This point reflects the monitoring of the mass effects of clot, which directly sticks to the sensor surface.
This reveals the adhesion of plasma clot on the surface of sensor coating in the form of distinctive frequency (Δf (Hz)) and dissipation (damping) (ΔΓ (Hz)) shifts.
Here, Bandwidth (Δ Γ Hz) and dissipation (D) have the same meaning, and they are related according to this equation.
Δ Γ (Hz) = 2D/fn fn is the resonance frequency of quartz crystal at overtone n.
for QCM-D platform, and comparison with those of "gold standard" in parallel. These reports are outstanding in the terms of the lowest sample/reagent volume consumption applied ever for coagulation tests. These factors are marvelous support for POC settings on the basis of cost-effectiveness. Whole blood applications of QCM-D technique have an advantage of its application in surgical room for monitoring of suitable dose of anticoagulant for proper outcomes and therapeutic directions while surgery. On the other hand, plasma applications reveal information of fibrinogen along with coagulation times and whole kinetics. This factor eliminates additional tests for fibrinogen calculation such as Clauss or modified Clauss methods on standard coagulometer. All these factors are substantial in the perspectives of robustness, cost-effectiveness and straightforwardness of the assays for laboratory/clinical research perspectives. Coagulation based QCM-D assays offer a better alternatives to those of 'gold standard'. Furthermore, QCM-D technique has a powerful potential of shortened coagulation times by means of ultra-sensitivity sensor thin films, biomedical engineering, miniaturization and simultaneous applications of different assays via sensor arrays. These reports are a proof of principle for coagulation assays on QCM-D platform and ultra-refine the POC settings for laboratory methods. 
Thromboplastin time (PT)
Measurements of haemostasis parameters such as thromboplastin time (PT) have fundamental importance in many clinical settings including extensive surgery, dialysis, innate coagulation disorders, or hemostatic effect of drugs with inflammatory potency 10 . In such conditions, assessment of the patient"s haemostasis status is substantial for suitable therapeutic directions and decisions 11, 12 . First and an exact PT based QCM-D tests alternative to clinical standard coagulometer with significantly enhanced robustness and reusability reported by Hussain et al 13, 14 . redundancy, yet they are mostly performed together 16 . Heparin is the most charge-dense naturally occurring polyanion molecule known in biology. It is a linear polysaccharide and it consists mainly of 1-4 linked uronic acid and glucosamine subunits.
Heparin Structure can be seen in figure 4 .
Sulfation groups in different degrees along disaccharide construct heparin the most structurally complex molecule of the glycosaminoglycan (GAG) class having the polymer Mr spanning ca.
2500-25 000 Da. In surgery, heparin doses in the blood or plasma are controlled by means of aPTT test to ensure the correct amount administration for desired results 23 . Surprisingly, this area has got an attention from multidisciplinary experts of every substantial part of science in the terms of laboratory and clinical methods [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] . Heparin detection at lower concentration doses is a chellange 13 . The first approach via molecular imprinting on QCM-D platform has been documented recently, and has been demonstrated in figure 5 35 . 
'Prothrombinase induced Clotting Time' (PiCT)
PiCT scientifically could be a universal assay for anticoagulants detection in laboratory and clinics, but it has not been recognized.
PiCT is comparatively a newly launched coagulation assay that Although aPTT is the most-used coagulation test, its results are extremely variable among different individuals, and it lacks precision and accuracy. Furthermore, it is insensitive to drugs, for example low molecular weight heparin and direct factor Xa inhibitors. aPTT and
PiCT donot correlate to each other 38 , while PiCT could reduce the flaws of aPTT [39] [40] [41] [42] [43] [44] .
PiCT for whole blood on QCM-D platform for anticoagulant detection has been recognized and reported recently by Hussain 45 . This report has employed the lowest sample volume of human whole blood (and Its further extension to direct whole blood method could be more interesting. These reports could yield assets for coagulation assays on QCM-D platform and ultra-refine the POC settings for laboratory and clinical methods levels in real practices worldwide.
Acknowledgements
Dr F.K. Gehring, Prof. Dr. H. Northoff and Oksana Faul are highly acknowledged and appreciated for moral support.
Competing interests
Author declares no competing interests.
Author's contributions
MH conceived idea, planned and wrote the manuscript.
